Glecaprevir/Pibrentasvir · more major-labeled pairs than Fluvastatin

SPL labels Fluvastatin + Glecaprevir/Pibrentasvir as minor; Fluvastatin 5 / Glecaprevir/Pibrentasvir 26 in that band.

Mechanism on file: This combination can lead to higher-than-normal levels of fluvastatin in your bloodstream.

FDA SPL severity: Minor

Fluvastatin

Full Fluvastatin label record

HMG-CoA Reductase Inhibitor (Statin)

Glecaprevir/Pibrentasvir

Full Glecaprevir/Pibrentasvir label record

NS3/4A/NS5A Inhibitor (HCV)

Fluvastatin + Glecaprevir/Pibrentasvir · SPL mechanism field

This combination can lead to higher-than-normal levels of fluvastatin in your bloodstream.

Minor band excerpt · Fluvastatin with Glecaprevir/Pibrentasvir

Fluvastatin Pitavastatin ↑ fluvastatin ↑ pitavastatin Coadministration may increase the concentrations of fluvastatin and pitavastatin. Use the lowest approved dose of fluvastatin or pitavastatin.

Glecaprevir/Pibrentasvir · 3 major-labeled pairs (vs Fluvastatin's 1)

View all Glecaprevir/Pibrentasvir interactions →

FDA Drug Labels (SPL) via openFDA. Registry display only. Not medical advice.